Your browser is no longer supported. Please, upgrade your browser.
Organogenesis Holdings Inc.
Index- P/E167.66 EPS (ttm)0.13 Insider Own54.20% Shs Outstand116.71M Perf Week-6.04%
Market Cap2.89B Forward P/E94.54 EPS next Y0.23 Insider Trans7.96% Shs Float26.73M Perf Month20.22%
Income17.90M PEG3.77 EPS next Q-0.02 Inst Own40.20% Short Float6.93% Perf Quarter126.13%
Sales338.30M P/S8.55 EPS this Y136.40% Inst Trans65.20% Short Ratio2.21 Perf Half Y467.72%
Book/sh1.25 P/B17.17 EPS next Y104.50% ROA7.40% Target Price21.50 Perf Year640.00%
Cash/sh0.63 P/C34.27 EPS next 5Y44.46% ROE25.00% 52W Range2.90 - 24.34 Perf YTD184.99%
Dividend- P/FCF- EPS past 5Y199.90% ROI12.60% 52W High-14.04% Beta1.46
Dividend %- Quick Ratio2.10 Sales past 5Y- Gross Margin74.20% 52W Low621.38% ATR1.76
Employees910 Current Ratio2.60 Sales Q/Q43.20% Oper. Margin8.80% RSI (14)56.26 Volatility8.65% 9.39%
OptionableYes Debt/Eq0.58 EPS Q/Q413.50% Profit Margin5.30% Rel Volume0.42 Prev Close21.46
ShortableNo LT Debt/Eq0.44 EarningsMay 10 AMC Payout0.00% Avg Volume837.53K Price20.92
Recom1.20 SMA202.38% SMA5022.41% SMA200158.59% Volume338,555 Change-2.52%
Jan-10-20Initiated SVB Leerink Outperform $9
Aug-26-19Resumed Credit Suisse Outperform $9 → $10
May-02-19Initiated Credit Suisse Outperform $9
Apr-17-19Initiated Oppenheimer Outperform $11
Apr-11-19Initiated SunTrust Buy $11
Apr-12-21 07:30AM  
Mar-26-21 10:21AM  
Mar-17-21 10:49AM  
Mar-16-21 11:00PM  
Mar-09-21 12:30PM  
Mar-08-21 03:42AM  
Mar-04-21 06:24PM  
Feb-16-21 07:00AM  
Feb-09-21 04:05PM  
Feb-08-21 04:05PM  
Feb-04-21 11:22AM  
Jan-20-21 12:20PM  
Jan-14-21 08:30AM  
Jan-13-21 04:05PM  
Jan-11-21 09:01AM  
Jan-07-21 03:47AM  
Jan-05-21 04:05PM  
Dec-04-20 12:20PM  
Nov-23-20 12:24AM  
Nov-18-20 02:11AM  
Nov-13-20 12:45AM  
Nov-10-20 05:40PM  
Nov-09-20 05:01PM  
Nov-02-20 04:30PM  
Oct-15-20 01:30PM  
Oct-14-20 04:30PM  
Oct-12-20 03:30PM  
Sep-17-20 04:05PM  
Sep-03-20 04:05PM  
Sep-02-20 12:05PM  
Aug-24-20 04:05PM  
Aug-11-20 02:30AM  
Aug-10-20 06:25PM  
Aug-03-20 12:31PM  
Jul-23-20 04:05PM  
Jul-15-20 07:30AM  
Jun-29-20 07:30AM  
Jun-05-20 01:11PM  
May-26-20 12:06PM  
May-12-20 12:30PM  
May-11-20 08:25PM  
Apr-13-20 04:05PM  
Apr-08-20 04:05PM  
Mar-30-20 07:38AM  
Mar-25-20 09:15AM  
Mar-13-20 10:49AM  
Mar-09-20 04:05PM  
Feb-21-20 07:30AM  
Feb-11-20 05:43AM  
Jan-27-20 10:37AM  
Jan-23-20 04:05PM  
Jan-13-20 07:00AM  
Nov-21-19 10:04PM  
Nov-20-19 07:25AM  
Nov-19-19 04:01PM  
Nov-12-19 04:05PM  
Nov-11-19 11:22AM  
Oct-11-19 04:05PM  
Oct-05-19 09:00AM  
Sep-17-19 07:30AM  
Sep-06-19 04:06PM  
Aug-19-19 04:57PM  
Aug-09-19 01:24PM  
Jul-22-19 04:15PM  
Jul-08-19 08:00AM  
Jul-01-19 07:30AM  
May-10-19 12:17PM  
May-01-19 08:30AM  
Apr-30-19 08:30AM  
Apr-02-19 07:30AM  
Apr-01-19 08:30AM  
Mar-18-19 04:05PM  
Mar-14-19 04:05PM  
Mar-12-19 09:00AM  
Mar-11-19 07:30AM  
Mar-04-19 09:00AM  
Feb-25-19 08:00AM  
Jan-24-19 10:00AM  
Jan-07-19 05:54PM  
Organogenesis Holdings Inc., a regenerative medicine company, develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic allograft wound covering and surgical barrier for application in the care of chronic and acute wounds or surgical implantation in spine, orthopedic, and sports medicine applications; Apligraf, a bioengineered bi-layered skin substitute for the treatment of venous leg ulcers and diabetic foot ulcers (DFUs); Dermagraft, a dermal substitute for the treatment of DFUs; NuShield, a dehydrated placental tissue wound covering and surgical barrier applied to the target tissue to support native healing; and PuraPly Antimicrobial, an antimicrobial barrier skin substitute to treat chronic and acute wounds. Its surgical and sports medicine products comprise NuCel, a surgically implanted allograft used primarily in spinal and orthopedic surgical applications; ReNu, a cryopreserved suspension used to support healing of soft tissues; and FiberOS and OCMP used as a bone void filler primarily in orthopedic and neurosurgical applications. The company's pipeline products include PuraPly XT and PuraPly MZ to treat chronic, acute, and open wounds; PuraForce, a bioengineered porcine collagen surgical matrix for use in soft tissue reinforcement applications; Novachor, a chorionic membrane wound covering; TransCyte, a bioengineered tissue for the treatment of partial thickness burns; and Gintuit, a bioengineered bi-layered living cellular tissue for the treatment of mucogingival conditions in adults. It serves hospitals, wound care centers, government facilities, ambulatory service centers, and physician office through direct sales force and independent agencies. The company was founded in 1985 and is headquartered in Canton, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Gillheeney Gary S.President and CEOFeb 18Sale12.8516,663214,120139,807Feb 18 08:34 PM
Gillheeney Gary S.President and CEOFeb 17Sale13.3789,3751,194,498156,470Feb 18 08:34 PM
Gillheeney Gary S.President and CEOFeb 16Sale13.12111,4061,461,647194,219Feb 16 09:57 PM
Gillheeney Gary S.President and CEOFeb 12Sale13.20111,3291,469,871305,625Feb 16 09:57 PM
Gillheeney Gary S.President and CEOFeb 11Sale13.8269,127955,335416,954Feb 16 09:57 PM
NUSSDORF GLENN HDirectorFeb 11Sale3.25200,000650,00068,594,976Feb 16 08:15 PM
Ades Alan A.DirectorFeb 11Sale3.25200,000650,00068,594,976Feb 16 08:12 PM
MACKIE WAYNE DDirectorDec 02Buy5.2638,710203,615200,000Dec 03 08:10 PM
Avista Capital Managing MemberDirectorNov 24Buy5.0010050029,924,515Nov 24 06:10 PM
Avista Capital Managing MemberDirectorNov 20Buy4.992,73913,67129,924,415Nov 24 06:10 PM
Avista Capital Managing MemberDirectorNov 19Buy4.9736,127179,61329,921,676Nov 19 07:14 PM
Avista Capital Managing MemberDirectorNov 18Buy4.6845,378212,51929,885,549Nov 19 07:14 PM
Avista Capital Managing MemberDirectorNov 17Buy3.264,322,65714,108,54029,840,171Nov 19 07:14 PM
KATZ MICHAEL W10% OwnerNov 17Buy3.2520,82967,69434,432Nov 19 05:21 PM
MACKIE WAYNE DDirectorNov 17Buy3.2542,726138,860161,290Nov 19 05:10 PM
Leibowitz Arthur SDirectorNov 17Buy3.256,94322,56530,507Nov 19 05:05 PM
NUSSDORF GLENN HDirectorNov 17Buy3.25347,1531,128,24768,794,976Nov 19 04:55 PM
NUSSDORF GLENN HDirectorNov 17Buy3.25486,0001,579,50068,447,823Nov 19 04:55 PM
Ades Alan A.DirectorNov 17Buy3.25347,1531,128,24768,794,976Nov 19 04:53 PM
Ades Alan A.DirectorNov 17Buy3.25486,0001,579,50068,447,823Nov 19 04:53 PM